Due to the overexpression of SPARC protein in the RA joint microenvironment and the inherent high affinity of SPARC for albumin, as well as the structural similarities between MTX and folic acid, BMC could be specifically targeted to the site of RA inflammation and anti‐inflammatory M1 macrophages. This evidence concerns the gene SPARC and rheumatoid arthritis.